[SCHEDULE 13G/A] Core Laboratories Inc. /DE/ SEC Filing
Core Laboratories Inc. (CLB): The Vanguard Group filed Amendment No. 3 to Schedule 13G, reporting beneficial ownership of 3,047,390 shares of common stock, representing 6.49% of the class as of 09/30/2025.
Vanguard reports 0 shares with sole voting power and 287,217 shares with shared voting power. It has 2,714,143 shares with sole dispositive power and 333,247 shares with shared dispositive power. Vanguard is identified as an investment adviser (IA), and states the securities were acquired and are held in the ordinary course of business. Vanguard’s clients have the right to receive dividends or sale proceeds related to these shares, and no single client’s interest exceeds 5%. The filing includes a certification that the holdings were not acquired to change or influence control of the issuer.
- None.
 
- None.
 
Insights
Passive 13G/A shows Vanguard at 6.49% of CLB.
The Vanguard Group disclosed beneficial ownership of 3,047,390 shares of Core Laboratories, or 
Voting rights are limited: 0 shares with sole voting power and 287,217 with shared voting power. Dispositive power is primarily sole (2,714,143 shares), with 333,247 shared, consistent with an investment adviser structure.
The certification states the position was acquired in the ordinary course and not to influence control. Vanguard notes client economic rights and that no single client exceeds